carbazole has been researched along with Alloxan Diabetes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Begum, NA; Fouzder, C; Karmakar, A; Kundu, R; Mallick, T; Mandal, J; Mondal, S; Mukhuty, A; Pramanik, A | 1 |
| Bersot, R; Humphries, PS; Kincaid, J; Mabery, E; McCluskie, K; Park, T; Renner, T; Riegler, E; Steinfeld, T; Turtle, ED; Wei, ZL; Willis, E | 2 |
3 other study(ies) available for carbazole and Alloxan Diabetes
| Article | Year |
|---|---|
Exploring the Propensities of Fluorescent Carbazole Analogs toward the Inhibition of Amyloid Aggregation in Type 2 Diabetes: An Experimental and Theoretical Endeavor.
Topics: Amyloid; Amyloidosis; Animals; Carbazoles; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Mice | 2021 |
Carbazole-containing amides and ureas: Discovery of cryptochrome modulators as antihyperglycemic agents.
Topics: Amides; Animals; Carbazoles; Cryptochromes; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Discovery; Hypoglycemic Agents; Male; Mice; Molecular Structure; Obesity; Structure-Activity Relationship; Urea | 2018 |
Carbazole-containing sulfonamides and sulfamides: Discovery of cryptochrome modulators as antidiabetic agents.
Topics: Animals; Blood Glucose; Carbazoles; Cell Line, Tumor; Cryptochromes; Diabetes Mellitus, Experimental; Diet, High-Fat; Gene Expression Regulation; Genes, Reporter; Humans; Hypoglycemic Agents; Mice; Mice, Inbred C57BL; Mice, Obese; Structure-Activity Relationship; Sulfonamides | 2016 |